SAN DIEGO, Feb. 15, 2018 /PRNewswire/ — Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), an ophthalmology-focused pharmaceutical company, today announced it will release fourth quarter 2017 financial results after the close of trading on Thursday, March 8, 2018. The company will host a…